You are here
- Home
- Therapy Areas
- Cardiovascular
Reversal of Ventricular Remodeling With Toprol-XL
- Disease
- congestive heart failure
- Drug Name
- Seloken ZOK/Toprol XL
- Generic Name
- metoprolol CR/XL
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- III
- Start Date
- Aug 1, 2001
- Study Name
- 276
- Study Id
- 276
- ClinicalTrials.gov ID
- NCT00038077
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
